James G. Thomasch
CEO & President
clinical science
clinquest
Netherlands
Biography
Mr. Thomasch recently joined Clinquest as CEO in May 2011. He is responsible for directing and overseeing all company activities in the areas of product development consulting, clinical trial implementation services and post-market approval compliance, reporting and pharmacovigilance safety monitoring activities.
Research Interest
Infectious Diseases & Preventive Medicine